美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ATYR PHARMA INC

5.19

-0.1150-2.17%

成交量：270.76万

成交额：1,410.47万

市值：4.61亿

市盈率：-6.49

高：5.45

开：5.38

低：5.12

收：5.30

数据加载中...

总览公司新闻公告

aTyr Pharma Inc 报告截至 3 月 31 日的季度业绩 - 收益摘要

Atyr Pharma, Inc.盘中异动急速跳水5.11%

Atyr Pharma, Inc.盘中异动大幅下跌5.03%

Atyr Pharma, Inc.盘中异动股价大涨5.09%报3.51美元

Atyr Pharma, Inc.盘中异动下午盘股价大涨5.20%

Atyr Pharma, Inc.盘中异动股价大涨5.07%

aTyr Pharma Inc 预计每股亏损19美分 - 财报前瞻

Atyr Pharma, Inc.盘中异动股价大涨5.18%

Atyr Pharma, Inc.盘中异动早盘快速拉升5.05%报3.26美元

Atyr Pharma, Inc.盘中异动股价大涨5.11%

Atyr Pharma, Inc.盘中异动急速跳水5.05%报2.73美元

Atyr Pharma, Inc.盘中异动股价大跌5.51%

Atyr Pharma, Inc.盘中异动急速下跌9.54%

Atyr Pharma, Inc.盘中异动大幅跳水5.01%

Atyr Pharma, Inc.盘中异动早盘急速跳水5.24%报2.81美元

Atyr Pharma, Inc.2024财年实现净利润-64.02百万美元，同比减少27.05%

aTyr Pharma Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要

aTyr Pharma Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要

aTyr Pharma公布第四季度每股亏损$0.18，优于预期$0.23

Atyr Pharma, Inc.股价拉升10.00% 市值涨3178.01万美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/ATYR/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATYR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATYR\",,,,,undefined,":{"symbol":"ATYR","market":"US","secType":"STK","nameCN":"ATYR PHARMA INC","latestPrice":5.185,"timestamp":1752000279872,"preClose":5.3,"halted":0,"volume":2707555,"delay":0,"floatShares":86983812,"shares":89004436,"eps":-0.799018,"marketStatus":"交易中","change":-0.115,"latestTime":"07-08 14:44:49 EDT","open":5.38,"high":5.45,"low":5.115,"amount":14104702.631051501,"amplitude":0.063208,"askPrice":5.19,"askSize":2792,"bidPrice":5.18,"bidSize":728,"shortable":3,"etf":0,"ttmEps":-0.799018,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752004800000},"marketStatusCode":2,"adr":0,"listingDate":1430971200000,"exchange":"NASDAQ","adjPreClose":5.3,"preHourTrading":{"tag":"盘前","latestPrice":5.36,"preClose":5.3,"latestTime":"09:28 EDT","volume":7649,"amount":40777.1058375,"timestamp":1751981313077},"postHourTrading":{"tag":"盘后","latestPrice":5.25,"preClose":5.3,"latestTime":"19:40 EDT","volume":22126,"amount":116725.8761,"timestamp":1751931615733},"volumeRatio":0.858215,"impliedVol":1.0326,"impliedVolPercentile":0.192},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATYR\",,,,,undefined,":{"symbol":"ATYR","floatShares":86983812,"roa":"-39.82%","roe":"-79.70%","lyrEps":-0.862131,"volumeRatio":0.858215,"shares":89004436,"dividePrice":0,"high":5.45,"amplitude":0.063208,"preClose":5.3,"low":5.115,"week52Low":1.48,"pbRate":"6.15","week52High":5.98,"institutionHeld":0,"latestPrice":5.185,"committee":-0.586364,"eps":-0.799018,"divideRate":0,"volume":2707555,"delay":0,"ttmEps":-0.799018,"open":5.38,"prevYearClose":3.62,"prevWeekClose":5.31,"prevMonthClose":5.07,"prevQuarterClose":5.07,"fiveDayClose":5.07,"twentyDayClose":5.38,"sixtyDayClose":2.87},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATYR\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533964867","title":"aTyr Pharma Inc 报告截至 3 月 31 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2533964867","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533964867?lang=zh_cn&edition=fundamental","pubTime":"2025-05-08 04:36","pubTimestamp":1746650205,"startTime":"0","endTime":"0","summary":"aTyr Pharma Inc 报告截至 3 月 31 日的季度业绩 - 收益摘要aTyr Pharma Inc ATYR.OQ报告，截至3月31日的季度调整后每股亏损17美分，高于去年同期的每股-23美分。九位分析师对该季度的平均预期是每股亏损 19 美分。aTyr Pharma Inc 公布的季度每股收益为亏损 17 美分。该公司当季亏损 1488 万美元。aTyr Pharma Inc 的股价本季度上涨了 7.0%，今年迄今为止下跌了 10.8%。华尔街对 aTyr Pharma Inc 的 12 个月目标价中位数为 16.50 美元。本摘要由 LSEG 5 月 7 日 08:36 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nL4T3RF29G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2533931296","title":"Atyr Pharma, Inc.盘中异动 急速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533931296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533931296?lang=zh_cn&edition=fundamental","pubTime":"2025-05-07 22:19","pubTimestamp":1746627596,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日22时19分，Atyr Pharma, Inc.股票出现波动，股价快速下挫5.11%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.76%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Zyversa Therapeutics, Inc.涨幅较大，Theriva Biologics, Inc.、Zyversa Therapeutics, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1510.79%、1264.68%、173.38%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Theriva Biologics, Inc.，振幅分别为130.71%、57.00%、44.12%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050722195697520f06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050722195697520f06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2533632213","title":"Atyr Pharma, Inc.盘中异动 大幅下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533632213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533632213?lang=zh_cn&edition=fundamental","pubTime":"2025-05-06 21:59","pubTimestamp":1746539942,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日21时59分，Atyr Pharma, Inc.股票出现波动，股价大幅跳水5.03%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为4.01%。其相关个股中，Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃，换手率分别为3689.50%、966.68%、257.34%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为107.74%、38.46%、30.65%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062159029750c561&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062159029750c561&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","ATYR","BK4139"],"gpt_icon":0},{"id":"2532844510","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.09%报3.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532844510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532844510?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 21:41","pubTimestamp":1746193305,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时41分，Atyr Pharma, Inc.股票出现异动，股价大幅拉升5.09%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.47%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Impact Biomedical, Inc.、Adaptive Biotechnologies Corporation涨幅较大，Pmgc Holdings Inc.、Adial Pharmaceuticals, Inc、Impact Biomedical, Inc.较为活跃，换手率分别为262.38%、66.35%、66.08%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Pmgc Holdings Inc.、Adaptive Biotechnologies Corporation，振幅分别为67.34%、22.59%、21.71%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502214145a6d11efb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502214145a6d11efb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2531612977","title":"Atyr Pharma, Inc.盘中异动 下午盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531612977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531612977?lang=zh_cn&edition=fundamental","pubTime":"2025-04-30 01:19","pubTimestamp":1745947182,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日01时19分，Atyr Pharma, Inc.股票出现异动，股价急速拉升5.20%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Kala Bio, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Onconetix, Inc.、Ibio, Inc.较为活跃，换手率分别为169.36%、154.33%、113.20%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为134.52%、54.29%、50.68%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430011942a46c7820&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430011942a46c7820&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2530628628","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530628628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530628628?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 21:31","pubTimestamp":1745847102,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时31分，Atyr Pharma, Inc.股票出现波动，股价快速拉升5.07%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1164.08%、311.75%、62.00%，振幅较大的相关个股有Portage Biotech Inc.、Galmed Pharmaceuticals Ltd.、Exozymes Inc.，振幅分别为16.55%、10.82%、10.07%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213142aa2c7cc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428213142aa2c7cc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0},{"id":"2530772124","title":"aTyr Pharma Inc 预计每股亏损19美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2530772124","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530772124?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 19:35","pubTimestamp":1745840110,"startTime":"0","endTime":"0","summary":"aTyr Pharma Inc 预计每股亏损19美分 - 财报前瞻aTyr Pharma Inc ATYR.OQ ATYR.O预计在4月30日发布业绩报告时，。LSEG的分析师平均预计aTyr Pharma Inc每股亏损19美分。华尔街对 aTyr Pharma Inc 的 12 个月目标价中位数为 16.50 美元，高于其上一次收盘价 3.35 美元。4月28日 - 以前的季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL4T3R60Y5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR"],"gpt_icon":0},{"id":"2529885586","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529885586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529885586?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 21:40","pubTimestamp":1745329206,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时40分，Atyr Pharma, Inc.股票出现波动，股价大幅上涨5.18%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、阿诺医药、60 Degrees Pharmaceuticals, Inc.涨幅较大，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ibio, Inc.较为活跃，换手率分别为172.78%、95.25%、41.21%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、60 Degrees Pharmaceuticals, Inc.、Vincerx Pharma, Inc.，振幅分别为23.53%、21.49%、18.83%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221400794de34a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221400794de34a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2529383140","title":"Atyr Pharma, Inc.盘中异动 早盘快速拉升5.05%报3.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529383140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529383140?lang=zh_cn&edition=fundamental","pubTime":"2025-04-21 22:24","pubTimestamp":1745245483,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时24分，Atyr Pharma, Inc.股票出现异动，股价大幅拉升5.05%。截至发稿，该股报3.26美元/股，成交量21.8709万股，换手率0.25%，振幅6.45%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421222443a4612c28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421222443a4612c28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2526675826","title":"Atyr Pharma, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526675826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526675826?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 21:43","pubTimestamp":1744379020,"startTime":"0","endTime":"0","summary":"北京时间2025年04月11日21时43分，Atyr Pharma, Inc.股票出现异动，股价大幅拉升5.11%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Conduit Pharmaceuticals Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Conduit Pharmaceuticals Inc.、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为252.18%、198.62%、54.65%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为37.40%、29.82%、25.23%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041121434097356d28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041121434097356d28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2526359505","title":"Atyr Pharma, Inc.盘中异动 急速跳水5.05%报2.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526359505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526359505?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 21:32","pubTimestamp":1744291928,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日21时32分，Atyr Pharma, Inc.股票出现波动，股价大幅下跌5.05%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Pasithea Therapeutics Corp.涨幅较大，Pmgc Holdings Inc.、Pasithea Therapeutics Corp.、Brainstorm Cell Therapeutics Inc.较为活跃，换手率分别为1604.82%、1531.64%、79.51%，振幅较大的相关个股有Viking Therapeutics, Inc.、戴纳基、Pasithea Therapeutics Corp.，振幅分别为97.32%、96.82%、31.19%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213208973452f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213208973452f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","KTTA","BK4139"],"gpt_icon":0},{"id":"2526393000","title":"Atyr Pharma, Inc.盘中异动 股价大跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526393000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526393000?lang=zh_cn&edition=fundamental","pubTime":"2025-04-09 22:06","pubTimestamp":1744207571,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日22时06分，Atyr Pharma, Inc.股票出现异动，股价急速下挫5.51%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为1.83%。其相关个股中，Phio Pharmaceuticals Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Hepion Pharmaceuticals, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Aditxt, Inc.较为活跃，换手率分别为2315.21%、1868.43%、196.42%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Phio Pharmaceuticals Corp.、Hepion Pharmaceuticals, Inc.，振幅分别为107.34%、73.27%、39.78%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409220611aa2c6505&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409220611aa2c6505&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2525231046","title":"Atyr Pharma, Inc.盘中异动 急速下跌9.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525231046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525231046?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 21:41","pubTimestamp":1744033312,"startTime":"0","endTime":"0","summary":"北京时间2025年04月07日21时41分，Atyr Pharma, Inc.股票出现异动，股价急速跳水9.54%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为2.98%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Apollomics Inc C/Wts 01/04/2028 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Transcode Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为59.44%、22.99%、22.00%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cingulate Inc C/Wts 10/12/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为70.15%、40.22%、32.44%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407214152a6b2c275&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407214152a6b2c275&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2524020352","title":"Atyr Pharma, Inc.盘中异动 大幅跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524020352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524020352?lang=zh_cn&edition=fundamental","pubTime":"2025-04-04 21:42","pubTimestamp":1743774127,"startTime":"0","endTime":"0","summary":"北京时间2025年04月04日21时42分，Atyr Pharma, Inc.股票出现波动，股价急速下跌5.01%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Impact Biomedical, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Impact Biomedical, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为1921.06%、462.15%、295.97%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Boundless Bio, Inc.、Cellectis Ads Each Repr 1 Ord Spon，振幅分别为127.32%、100.00%、98.33%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404214207a6afb3d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250404214207a6afb3d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2524263718","title":"Atyr Pharma, Inc.盘中异动 早盘急速跳水5.24%报2.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524263718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524263718?lang=zh_cn&edition=fundamental","pubTime":"2025-04-03 21:53","pubTimestamp":1743688432,"startTime":"0","endTime":"0","summary":"北京时间2025年04月03日21时53分，Atyr Pharma, Inc.股票出现异动，股价急速下跌5.24%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Protagenic Therapeutics, Inc.、Aptevo Therapeutics Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Aptevo Therapeutics Inc.、Protagenic Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为3014.70%、1431.02%、342.09%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Protagenic Therapeutics, Inc.、Context Therapeutics Inc.，振幅分别为84.06%、65.20%、38.77%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于通过其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040321535394cb308c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040321535394cb308c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2520293968","title":"Atyr Pharma, Inc.2024财年实现净利润-64.02百万美元，同比减少27.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2520293968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520293968?lang=zh_cn&edition=fundamental","pubTime":"2025-03-19 08:00","pubTimestamp":1742342436,"startTime":"0","endTime":"0","summary":"3月19日，Atyr Pharma, Inc.公布财报，公告显示公司2024财年净利润为-64.02百万美元，同比减少27.05%；其中营业收入为235000.00美元，同比减少33.43%，每股基本收益为-0.86美元。从资产负债表来看，Atyr Pharma, Inc.总负债28.22百万美元，其中短期债务1.25百万美元，资产负债比为3.48，流动比率为5.48。机构评级：截至2025年3月19日，当前有10家机构对Atyr Pharma, Inc.目标价做出预测，其中目标均价为18.55美元，其中最低目标价为9.00美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250319080044a438dcf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250319080044a438dcf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR"],"gpt_icon":0},{"id":"2519864707","title":"aTyr Pharma Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2519864707","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519864707?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 05:02","pubTimestamp":1741899737,"startTime":"0","endTime":"0","summary":"aTyr Pharma Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要aTyr Pharma Inc ATYR.OQ报告，截至12月31日的季度调整后每股亏损18美分，高于去年同期的每股-25美分。报告收入为零，分析师预期为 1.11 万美元。aTyr Pharma Inc 公布的本季度每股收益为亏损 18 美分。该公司当季亏损 1497 万美元。本季度，aTyr Pharma Inc 的股价下跌了 1.9%。华尔街对 aTyr Pharma Inc 的 12 个月目标价中位数为 16.00 美元。本摘要由 LSEG 3 月 13 日 09:01 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL4T3PW1LB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"2519864702","title":"aTyr Pharma Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2519864702","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519864702?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 05:02","pubTimestamp":1741899737,"startTime":"0","endTime":"0","summary":"aTyr Pharma Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要aTyr Pharma Inc ATYR.OQ报告，截至12月31日的季度调整后每股亏损18美分，高于去年同期的每股-25美分。报告收入为零，分析师预期为 1.11 万美元。aTyr Pharma Inc 公布的本季度每股收益为亏损 18 美分。该公司当季亏损 1497 万美元。本季度，aTyr Pharma Inc 的股价下跌了 1.9%。华尔街对 aTyr Pharma Inc 的 12 个月目标价中位数为 16.00 美元。本摘要由 LSEG 3 月 13 日 09:01 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL4S3PW1LB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"gpt_icon":0},{"id":"1192466746","title":"aTyr Pharma公布第四季度每股亏损$0.18，优于预期$0.23","url":"https://stock-news.laohu8.com/highlight/detail?id=1192466746","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192466746?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 04:12","pubTimestamp":1741896752,"startTime":"0","endTime":"0","summary":"aTyr Pharma 报告其季度每股亏损$0.18，优于分析师普遍预期的每股亏损$0.23，超出21.74%。相比去年同期每股亏损$0.25，这是一个28%的改进。以上内容来自Benzinga Earnings专栏，原文如下：aTyr Pharma  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 21.74 percent. This is a 28 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"aTyr Pharma公布第四季度每股亏损$0.18，优于预期$0.23","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR"],"gpt_icon":0},{"id":"2519865996","title":"Atyr Pharma, Inc.股价拉升10.00% 市值涨3178.01万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2519865996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519865996?lang=zh_cn&edition=fundamental","pubTime":"2025-03-14 02:46","pubTimestamp":1741891583,"startTime":"0","endTime":"0","summary":"北京时间2025年03月14日02时46分，Atyr Pharma, Inc.股票出现波动，股价大幅上涨10.00%。截至发稿，该股报3.91美元/股，成交量117.535万股，换手率1.40%，振幅10.42%。Atyr Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Atyr Pharma, Inc.公司简介：aTyr Pharma Inc 是一家生物治疗公司，致力于从其专有的 tRNA 合成酶平台发现和开发一流的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314024623a1db8b36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314024623a1db8b36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATYR","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":64,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATYR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"ATYR","fiscalQuarterEnding":"2025/03","expectedEps":-0.19,"name":null,"time":"盘后","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2025-03-13","symbol":"ATYR","fiscalQuarterEnding":"2024/12","expectedEps":-0.23,"name":null,"time":"盘后","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2024-11-07","symbol":"ATYR","fiscalQuarterEnding":"2024/09","expectedEps":-0.22,"name":null,"time":"盘后","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2024-08-13","symbol":"ATYR","fiscalQuarterEnding":"2024/06","expectedEps":-0.22,"name":null,"time":"盘后","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2024-05-02","symbol":"ATYR","fiscalQuarterEnding":"2024/03","expectedEps":-0.24,"name":null,"time":"盘后","type":"earning","dateTimestamp":1714622400000,"reportTimeType":"post","actualEps":-0.23}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATYR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATYR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":10,"updateTime":1740024000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATYR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATYR","date":"2025-07-07","current":-7.453062,"percent":0.032,"low":-7.719744,"twenty":-5.034735,"median":-4.294031,"eighty":-2.448121,"high":-1.932291,"avg":-4.16604,"sd":1.46906,"marketCap":472613555},"quantilePoints":[{"date":"2024-06-07","current":-2.380173,"twenty":-2.380173,"median":-2.380173,"eighty":-2.380173,"marketCap":128360348},{"date":"2024-06-14","current":-2.367376,"twenty":-2.482546,"median":-2.431359,"eighty":-2.377614,"marketCap":127670239},{"date":"2024-06-21","current":-2.021867,"twenty":-2.446715,"median":-2.367376,"eighty":-2.203579,"marketCap":109037285},{"date":"2024-06-28","current":-1.970681,"twenty":-2.431359,"median":-2.367376,"eighty":-2.111444,"marketCap":106276847},{"date":"2024-07-05","current":-1.970681,"twenty":-2.431359,"median":-2.265003,"eighty":-1.991155,"marketCap":106276847},{"date":"2024-07-12","current":-2.073054,"twenty":-2.39041,"median":-2.092249,"eighty":-1.970681,"marketCap":111797722},{"date":"2024-07-15","current":-2.226613,"twenty":-2.380173,"median":-2.111444,"eighty":-1.970681,"marketCap":120079035},{"date":"2024-08-02","current":-2.495343,"twenty":-2.421122,"median":-2.130639,"eighty":-1.9758,"marketCap":134571333},{"date":"2024-08-09","current":-2.380173,"twenty":-2.403207,"median":-2.265003,"eighty":-1.996274,"marketCap":128360348},{"date":"2024-08-16","current":-2.618312,"twenty":-2.418704,"median":-2.296995,"eighty":-2.001393,"marketCap":151592396},{"date":"2024-08-23","current":-2.448121,"twenty":-2.445503,"median":-2.341783,"eighty":-2.021867,"marketCap":141738890},{"date":"2024-08-30","current":-2.474305,"twenty":-2.468042,"median":-2.373775,"eighty":-2.032104,"marketCap":143254814},{"date":"2024-09-06","current":-2.291023,"twenty":-2.461213,"median":-2.354579,"eighty":-2.073054,"marketCap":132643346},{"date":"2024-09-13","current":-2.448121,"twenty":-2.474305,"median":-2.380173,"eighty":-2.111444,"marketCap":141738890},{"date":"2024-09-20","current":-2.448121,"twenty":-2.474305,"median":-2.399368,"eighty":-2.149834,"marketCap":141738890},{"date":"2024-09-27","current":-2.277931,"twenty":-2.474305,"median":-2.382664,"eighty":-2.226613,"marketCap":131885384},{"date":"2024-10-04","current":-2.277931,"twenty":-2.469749,"median":-2.373775,"eighty":-2.226613,"marketCap":131885384},{"date":"2024-10-11","current":-2.77541,"twenty":-2.474305,"median":-2.382664,"eighty":-2.251748,"marketCap":160687939},{"date":"2024-10-18","current":-3.469263,"twenty":-2.48085,"median":-2.399368,"eighty":-2.251748,"marketCap":200859924},{"date":"2024-10-25","current":-4.241665,"twenty":-2.500488,"median":-2.421938,"eighty":-2.265003,"marketCap":245579681},{"date":"2024-10-31","current":-4.097658,"twenty":-2.555472,"median":-2.431359,"eighty":-2.275241,"marketCap":237242099},{"date":"2024-11-08","current":-4.058383,"twenty":-2.922036,"median":-2.441575,"eighty":-2.277905,"marketCap":234968213},{"date":"2024-11-15","current":-3.78886,"twenty":-3.621287,"median":-2.448121,"eighty":-2.277931,"marketCap":241789871},{"date":"2024-11-22","current":-3.919838,"twenty":-3.629704,"median":-2.448121,"eighty":-2.277931,"marketCap":250148372},{"date":"2024-11-29","current":-4.643298,"twenty":-3.916561,"median":-2.461213,"eighty":-2.285786,"marketCap":296316696},{"date":"2024-12-06","current":-4.301299,"twenty":-4.007344,"median":-2.474305,"eighty":-2.298878,"marketCap":274491670},{"date":"2024-12-13","current":-3.972453,"twenty":-4.100191,"median":-2.474305,"eighty":-2.31136,"marketCap":253506069},{"date":"2024-12-20","current":-4.143453,"twenty":-4.111931,"median":-2.474305,"eighty":-2.3168,"marketCap":264418582},{"date":"2024-12-27","current":-4.95899,"twenty":-4.144489,"median":-2.487396,"eighty":-2.317206,"marketCap":316462874},{"date":"2025-01-03","current":-5.143143,"twenty":-4.229494,"median":-2.500488,"eighty":-2.317206,"marketCap":328214811},{"date":"2025-01-10","current":-4.919528,"twenty":-4.267848,"median":-2.526671,"eighty":-2.317206,"marketCap":313944602},{"date":"2025-01-17","current":-4.932682,"twenty":-4.327606,"median":-2.579037,"eighty":-2.328986,"marketCap":314784026},{"date":"2025-01-24","current":-4.682759,"twenty":-4.341161,"median":-2.768865,"eighty":-2.330035,"marketCap":298834968},{"date":"2025-01-31","current":-4.919528,"twenty":-4.389843,"median":-2.932509,"eighty":-2.330297,"marketCap":313944602},{"date":"2025-02-07","current":-5.090528,"twenty":-4.509129,"median":-3.510289,"eighty":-2.339486,"marketCap":324857115},{"date":"2025-02-14","current":-4.722221,"twenty":-4.606467,"median":-3.575068,"eighty":-2.341783,"marketCap":301353241},{"date":"2025-02-21","current":-5.827142,"twenty":-4.643298,"median":-3.6107,"eighty":-2.357139,"marketCap":371864863},{"date":"2025-02-28","current":-5.090528,"twenty":-4.682759,"median":-3.851618,"eighty":-2.375054,"marketCap":324857115},{"date":"2025-03-07","current":-4.051376,"twenty":-4.682759,"median":-3.972453,"eighty":-2.380173,"marketCap":258542613},{"date":"2025-03-14","current":-5.248373,"twenty":-4.682759,"median":-3.985607,"eighty":-2.381668,"marketCap":334930203},{"date":"2025-03-21","current":-4.929845,"twenty":-4.727483,"median":-3.990774,"eighty":-2.382664,"marketCap":315623450},{"date":"2025-03-28","current":-4.52461,"twenty":-4.75379,"median":-4.035211,"eighty":-2.388848,"marketCap":289679075},{"date":"2025-04-04","current":-3.872289,"twenty":-4.740636,"median":-4.038222,"eighty":-2.400648,"marketCap":247915527},{"date":"2025-04-11","current":-3.802893,"twenty":-4.727483,"median":-4.011134,"eighty":-2.407615,"marketCap":243472596},{"date":"2025-04-17","current":-4.191509,"twenty":-4.722221,"median":-4.035211,"eighty":-2.414083,"marketCap":268353008},{"date":"2025-04-25","current":-4.788314,"twenty":-4.743267,"median":-4.051376,"eighty":-2.421938,"marketCap":306562211},{"date":"2025-05-02","current":-4.635643,"twenty":-4.743267,"median":-4.087671,"eighty":-2.425706,"marketCap":296787764},{"date":"2025-05-09","current":-4.680309,"twenty":-4.75642,"median":-4.108234,"eighty":-2.431359,"marketCap":296787764},{"date":"2025-05-16","current":-4.210769,"twenty":-4.743267,"median":-4.133647,"eighty":-2.432827,"marketCap":267013308},{"date":"2025-05-23","current":-5.333641,"twenty":-4.774836,"median":-4.143453,"eighty":-2.440266,"marketCap":338216856},{"date":"2025-05-30","current":-5.972275,"twenty":-4.816072,"median":-4.149872,"eighty":-2.448121,"marketCap":378713875},{"date":"2025-06-06","current":-7.509205,"twenty":-4.87282,"median":-4.17922,"eighty":-2.448121,"marketCap":476173732},{"date":"2025-06-13","current":-7.621493,"twenty":-4.919528,"median":-4.191509,"eighty":-2.448121,"marketCap":483294087},{"date":"2025-06-20","current":-7.256559,"twenty":-4.932682,"median":-4.241665,"eighty":-2.448121,"marketCap":460152934},{"date":"2025-06-27","current":-7.453062,"twenty":-4.985297,"median":-4.254757,"eighty":-2.448121,"marketCap":472613555},{"date":"2025-07-03","current":-7.453062,"twenty":-5.016231,"median":-4.28094,"eighty":-2.448121,"marketCap":472613555},{"date":"2025-07-07","current":-7.453062,"twenty":-5.034735,"median":-4.294031,"eighty":-2.448121,"marketCap":472613555}],"updateTime":1752000289307}}}